You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

ESCITALOPRAM Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Escitalopram patents expire, and when can generic versions of Escitalopram launch?

Escitalopram is a drug marketed by Norvium Bioscience, Amneal Pharms, Antrim Pharms Llc, Aurobindo Pharma Ltd, Chartwell Molecular, Hetero Labs Ltd Iii, Macleods Pharms Ltd, Taro, Accord Hlthcare, Chartwell Rx, Dash Pharms, Graviti Pharms, Hikma Pharms, Invagen Pharms, Jubilant Cadista, Pharm Assoc, Prinston Inc, Teva Pharms Usa, Torrent Pharms Ltd, and Zydus Lifesciences. and is included in twenty-three NDAs.

The generic ingredient in ESCITALOPRAM is escitalopram oxalate. There are twenty-six drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the escitalopram oxalate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Escitalopram

A generic version of ESCITALOPRAM was approved as escitalopram oxalate by AMNEAL PHARMS on March 14^th, 2012.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ESCITALOPRAM?
What are the global sales for ESCITALOPRAM?
What is Average Wholesale Price for ESCITALOPRAM?

Summary for ESCITALOPRAM

US Patents:	0
Applicants:	20
NDAs:	23
Drug Prices:	Drug price information for ESCITALOPRAM
Drug Sales Revenues:	Drug sales revenues for ESCITALOPRAM
DailyMed Link:	ESCITALOPRAM at DailyMed

Drug patent expirations by year for ESCITALOPRAM

Drug Prices for ESCITALOPRAM

US Patents and Regulatory Information for ESCITALOPRAM

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharm Assoc	ESCITALOPRAM OXALATE	escitalopram oxalate	TABLET;ORAL	077512-001	Sep 12, 2012		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Invagen Pharms	ESCITALOPRAM OXALATE	escitalopram oxalate	TABLET;ORAL	078604-001	Sep 11, 2012	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms Usa	ESCITALOPRAM OXALATE	escitalopram oxalate	TABLET;ORAL	076765-003	Mar 14, 2012		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Prinston Inc	ESCITALOPRAM OXALATE	escitalopram oxalate	TABLET;ORAL	078032-002	Aug 28, 2015	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.